Asian Spectator

Times Advertising

Publication of First In-Human Data Reveals Safety Efficacy o...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
BRISBANE, Australia, Dec. 9, 2019 /PRNewswire-AsiaNet/ -- - First in-human Clinical Phase I study of intratumoural tigilanol tiglate (EBC-46) has been published in The Lancet's EBioMedicine journal; - An efficacious dose was achieved and a Maximum Tolerated Dose (MTD) was not reached, indicating tigila...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Bukan ‘malas’, penampilan Justin Bieber di Coachella menunjukkan cara kita menikmati musik daring

Kevin Mazur/Getty Images for CoachellaSetelah empat tahun absen dari tur, Justin Bieber tampil sebagai penampil utama di panggung Coachella. Namun, aksinya memicu kontroversi saat ia bernyanyi diiring...

Sederhana tapi menjebak: Bahaya tersembunyi konsep ‘love language’ dalam hubungan

Tahukah kamu bagaimana caramu memberi dan menerima kasih sayang? Apakah kamu tipe orang yang lebih menyukai words of affirmation (ungkapan sayang lewat kata-kata) atau quality time (menghabiskan waktu...

Legal Risks Every Business Owner Should Know

Running a business in Australia comes with a degree of legal exposure that many owners underestimate until a problem is already at their door. From contractual disputes to employment matters, the le...